Importance of magnetic nanoparticles in daily life including biomedical applications in near future cannot be overlooked. This review focuses on the properties of magnetic nanoparticles (MNPs), various approaches for their synthesis, and their biomedical applications. First part of this review focuses on the classes, physical properties, and characteristics of MNPs. The second part sheds light on strategies developed for the synthesis of MNPs, with special attention given to biological, physical, and chemical approaches as well as recent modifications in the preparation of monodispersed samples. Furthermore, this review deals with the biomedical applications of MNPs, which includes applications in targeted drug delivery, diagnostics, gene therapy, hyperthermia and advantages in the field of medicine.
Background: Tumor-targeted delivery by nanoparticles is a great achievement towards the use of highly effective drug at very low doses. The conventional development of tumor-targeted delivery by nanoparticles is based on enhanced permeability and retention (EPR) effect and endocytosis based on receptor-mediated are very demanding due to the biological and natural complications of tumors as well as the restrictions on the design of the accurate nanoparticle delivery systems. Methods: Different tumor environment stimuli are responsible for triggered multistage drug delivery systems (MSDDS) for tumor therapy and imaging. Physicochemical properties, such as size, hydrophobicity and potential transform by MSDDS because of the physiological blood circulation different, intracellular tumor environment. This system accomplishes tumor penetration, cellular uptake improved, discharge of drugs on accurate time, and endosomal discharge. Results: Maximum drug delivery by MSDDS mechanism to target therapeutic cells and also tumor tissues and sub cellular organism. Poorly soluble compounds and bioavailability issues have been faced by pharmaceutical industries, which are resolved by nanoparticle formulation. Conclusion: In our review, we illustrate different types of triggered moods and stimuli of the tumor environment, which help in smart multistage drug delivery systems by nanoparticles, basically a multi-stimuli sensitive delivery system, and elaborate their function, effects, and diagnosis.
Two commercially significant marine Pelecypoda species named Perna viridis (green mussel) and Paphia malabarica (short neck yellow clam) were exposed to different concentrations of Atrataf (commercial brand of atrazine available in India) in an acute toxicity test. The 96 h LC50 values of Atrataf to P. viridis and P. malabarica were 6.10 mg L-1, and 4.90 mg L-1 respectively. This study showed that there is a significant increase in mortality in both species as the dose and duration of Atrataf exposure are increased further, exposure to sublethal concentrations of the Atrataf. Moreover, following 14 days of exposure to sublethal doses of Atrataf, the immunotoxic potential of atrazine was examined by measuring viable haemocytes using the Tryphan Blue Exclusion Assay. After 14 days of exposure to the highest sublethal doses of Atrataf, the percentage of viable hemocytes decreased to 74.51 (Perna viridis) and 78.39 (Paphia malabarica), relative to the control. Since Haemocytes are the most critical cells in the immune system of Pelecypoda, any decrease in the hemocyte count will have a detrimental impact on the immune system activities. This is the first study of its kind study to investigate and report atrazine as a potential compound, which can induce immunotoxicity in Pelecypoda. The fact that the two studied species of Perna viridis and Paphia malabarica, are both commercially and ecologically important, their selection adds to the study’s significance.